Toggle Side Panel
Close search

Standford University Med School to Host Levosimendan Phase 2 Trial

  • Research & Development

    Standford University Med School to Host Levosimendan Phase 2 Trial

    Posted by Community Member on November 30, 2018 at 1:12 pm

    Stanford University School of Medicine is the first clinical site for a Phase 2 trial testing Tenax’s levosimendan candidate for the treatment of PH-HFpEF. Click here to read more.

    What other clinical trials are you interested in reading about?

    replied 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .